Trials / Recruiting
RecruitingNCT05433220
PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova
PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure (PROMPT-HF) at Inova
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5,000 (estimated)
- Sponsor
- Inova Health Care Services · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A randomized, single-blind intervention trial to test the comparative effectiveness of an electronic health record best practice advisory system that informs clinicians of guideline-indicated and FDA-approved heart failure medications currently not prescribed to their patients with heart failure versus usual care (no alert and how things are done currently). The purpose of the alert is to stimulate appropriate medication prescription for patients with heart failure and a reduced ejection fraction. This will be done across outpatient Inova clinics and at the five Inova hospitals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Best Practice Advisory using Electronic Health Record | Providers caring for patients randomized to the intervention arm will have a best practice alert appear for each of their eligible patients upon opening of the order entry screen in the patient's medical record. This alert informs the provider to the presence of HFrEF, notes the patient's current LVEF and current evidence-based medications, and gives access to an order set with recommended evidence- based, guideline-recommended, and FDA- approved therapies for patients with HFrEF. Providers will also have access to a link to best available guideline recommended information regarding treatment of heart failure to allow further education if desired by the provider. The alerts will also clearly state the expected monitoring and follow-up required for prescriptions of these medications. |
Timeline
- Start date
- 2022-08-25
- Primary completion
- 2026-06-01
- Completion
- 2026-08-01
- First posted
- 2022-06-27
- Last updated
- 2025-08-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05433220. Inclusion in this directory is not an endorsement.